Baskhanbiopharma (XKRX:354390) Total Current Assets : ₩19,742 Mil (As of Dec. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Baskhanbiopharma Total Current Assets?

Total current assets includes Cash, Cash Equivalents, Marketable Securities, Total Receivables, Total Inventories, and Other Current Assets. Baskhanbiopharma's total current assets for the quarter that ended in Dec. 2024 was ₩19,742 Mil.

Baskhanbiopharma Total Current Assets Historical Data

The historical data trend for Baskhanbiopharma's Total Current Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Baskhanbiopharma Total Current Assets Chart

Baskhanbiopharma Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Dec24

Total Current Assets

13,250.52

15,865.17

13,905.35

15,824.81

19,741.71

Baskhanbiopharma Semi-Annual Data
	Dec20	Dec21	Dec22	Dec23	Dec24
Total Current Assets	13,250.52	15,865.17	13,905.35	15,824.81	19,741.71

Baskhanbiopharma Total Current Assets Calculation

Total Current Assets are the asset that can be converted to cash or used to pay current liabilities within 12 months.

Baskhanbiopharma's Total Current Assets for the fiscal year that ended in Dec. 2024 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	5349.478	+	10249.285	+	4042.106	+	100.838
	=	19,742

Baskhanbiopharma's Total Current Assets for the quarter that ended in Dec. 2024 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	5349.478	+	10249.285	+	4042.106	+	100.838
	=	19,742

Total Current Assets is linked to the Current Ratio, which is the result of dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations.

Total Current Assets is also linked to Working Capital, Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

Baskhanbiopharma (XKRX:354390) Total Current Assets Explanation

In Ben Graham's calculation of liquidation value, inventory is only considered worth half of its book value, and accounts receivable is considered worth 75% of its value. Therefore the liquidation value is lower than calculated from total current assets.

Baskhanbiopharma's Liquidation Value for the quarter that ended in Dec. 2024 is

	Liquidation value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	5349.478	-	4401.511	+	0.75 * 10222.41	+	0.5 * 4042.106
=	10,636

Baskhanbiopharma Total Current Assets Related Terms

Thank you for viewing the detailed overview of Baskhanbiopharma's Total Current Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Baskhanbiopharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Baskhanbiopharma Inc (XKRX:354390) » Definitions » Total Current Assets

Traded in Other Exchanges

N/A

Address

354 Wondang-ro, Wongok-myeon, Anseong-si, Gyeonggi-do, KOR

Website

https://www.baskhanbio.com

Baskhanbiopharma Inc manufactures and distributes prescription drugs, over the counter drugs, medical devices and other related products.

Baskhanbiopharma Headlines

No Headlines